National Institute on Drug Abuse

Supporting scientific research on drug use and
addiction for 50 years

Receiving gold-standard care after a non-fatal overdose was associated with a decreased risk of subsequent overdose.

COVID-19 and increasingly dangerous drugs among factors that may have contributed to diminished impact of intervention

NIH-supported study highlights increasingly dangerous illicit drug supply, risk of pills not coming from a pharmacy

NIH-supported clinical trial addresses important barrier to opioid use disorder treatment

NIDA Points of Interest

Advancing the science on drug use and addiction

Nora D. Volkow, M.D., became Director of NIDA in May 2003.

Research grants, contracts, and supplements related to drug use and addiction.

Substance use screening tools, guidelines, and other resources.

Programs to support research training from high school through tenure.

Learn about NIDA-supported research and cross-agency research activities on drug use and addiction.

This video highlights fifty years of scientific achievements and NIDA’s continued mission to advance the science of addiction.

Monday, July 22, 2024 12:00pm to 1:30pm

| Virtual

Thursday, July 25, 2024 2:00pm to 3:30pm

| Virtual